AstraZeneca

Still chasing biosimilars? Multinational pharmaceutical companies have begun to sell
Pharmaceutical companies Biocon Adalimumab GlaxoSmithKline AstraZeneca Novartis
05-07
The "first stock of anti-cancer drugs" fell behind, and the three brothers turned against each other
Beida Pharmaceuticals Wang Yinxiang Exetinib Pharmaceutical companies AstraZeneca
04-18
Sneak peek! What are the highlights of this year's AACR?
clinical trial WuXi AppTec immunity cancer astrazeneca DNA damage imfinzi American Association for Cancer Research AstraZeneca atp
04-07
Myth shattered, Junshi PD-1 sales fell by 60%, soul bargaining does not back the pot
pd-1 Junshi Tripril monoclonal antibody Junshi Creatures AstraZeneca
04-01
Forward or retreat, AstraZeneca's grassroots war
AstraZeneca AstraZeneca China Business Unit grass roots
03-10
Fake crying miserable or real poverty? The annual results were released, and 7 pharmaceutical companies sold 20 billion yuan in China
Pharmaceutical companies Earnings Johnson Pfizer AstraZeneca Merck
02-15
Tampering with the genetic test results of tumor patients to defraud insurance, AstraZeneca 17 people fraud gang arrested
AstraZeneca Shenzhen Municipal Medical Insurance Bureau AstraZeneca China Shenzhen National Health Insurance Administration
02-11
Shenzhen Medical Insurance Bureau reported: AstraZeneca staff is suspected of cheating insurance and tampering with patient test results
National Health Insurance Administration AstraZeneca Shenzhen AstraZeneca Pharmaceuticals Shenzhen Municipal Public Security Bureau
02-11
Insufficient monitoring of the medical insurance key directory? The monopoly of drug sales remains
Health care Fujian Provincial Medical Insurance Bureau AstraZeneca Fujian
02-09
59 billion yuan! Henan released the online trading of drugs in the province in 2021
Henan Collective procurement Online trading AstraZeneca Hengrui
01-26
Global healthcare giants have "turned their backs", and the asian medical innovation outlet is accelerating from Singapore to China
Singapore_Technology Asia_Technology AstraZeneca Boston Scientific Shanghai
01-18
Finding a new outlet, PD-1 hopes to rekindle?
3SBio Group Sansheng Guojian AstraZeneca Junshi Creatures China Biopharma
01-06
Di Zhe Pharmaceutical: DZD8586 obtained the approval notice of drug clinical trials from the State Food and Drug Administration
Di Zhe Pharmaceutical State Food and Drug Administration Harvard Medical School AstraZeneca Boston University, USA Degree
01-05
A Vision for the New Year of Medicine People
AstraZeneca Executive Vice President Wang Lei Cinda Bio BeiGene
01-04